Fig. 6

The validation of the risk model for predicting the prognosis of cervical cancer. Survival analysis showing the OS of cervical cancer patients in the CGCI-HTMCP-CC dataset (high-risk group: n = 59; low-risk group, n = 59, A) and the DFS of cervical cancer patients in the GSE44001 dataset (high-risk group: n = 150; low-risk group, n = 150, B). C The AUCs for 12-, 18-, 24-, and 27-month ROC in the CGCI-HTMCP-CC cohort. D The AUCs for 12-, 24-, 36-, 48- and 60-month ROC in the GSE44001 cohort. E Comparison of the predictive ability of the dsRBP signatures with 10 previously reported risk models for cervical cancer. DFS disease-free survival